These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 30431618)
1. Prognostic and clinical value of Targeting protein for Xenopus kinesin-like protein 2 in patients with gastrointestinal tract cancers: A meta-analysis. Liu W; Xu J; Zhang C Medicine (Baltimore); 2018 Nov; 97(46):e13303. PubMed ID: 30431618 [TBL] [Abstract][Full Text] [Related]
2. TPX2 as a Novel Prognostic Indicator and Promising Therapeutic Target in Triple-negative Breast Cancer. Jiang Y; Liu Y; Tan X; Yu S; Luo J Clin Breast Cancer; 2019 Dec; 19(6):450-455. PubMed ID: 31494045 [TBL] [Abstract][Full Text] [Related]
3. TPX2 expression is associated with poor survival in gastric cancer. Tomii C; Inokuchi M; Takagi Y; Ishikawa T; Otsuki S; Uetake H; Kojima K; Kawano T World J Surg Oncol; 2017 Jan; 15(1):14. PubMed ID: 28069036 [TBL] [Abstract][Full Text] [Related]
4. Clinical value of Xenopus kinesin-like protein 2 as a prognostic marker in patients with digestive system cancers: a systematic review and meta-analysis. Wang G; Wang Q; Li Z; Liu C; He X Onco Targets Ther; 2018; 11():1229-1243. PubMed ID: 29551902 [TBL] [Abstract][Full Text] [Related]
5. Prognostic role of targeting protein for Xklp2 in solid tumors: A PRISMA-compliant systematic review and meta-analysis. Wang S; Chen Y; Chai Y Medicine (Baltimore); 2018 Oct; 97(43):e13018. PubMed ID: 30412141 [TBL] [Abstract][Full Text] [Related]
6. Integrative analysis confirms TPX2 as a novel biomarker for clinical implication, tumor microenvironment, and immunotherapy response across human solid tumors. Zhu M; Wang X; Zhang Q; Xie C; Wang T; Shen K; Zhang L; Zhou X Aging (Albany NY); 2024 Feb; 16(3):2563-2590. PubMed ID: 38315450 [TBL] [Abstract][Full Text] [Related]
7. RAN nucleo-cytoplasmic transport and mitotic spindle assembly partners XPO7 and TPX2 are new prognostic biomarkers in serous epithelial ovarian cancer. Cáceres-Gorriti KY; Carmona E; Barrès V; Rahimi K; Létourneau IJ; Tonin PN; Provencher D; Mes-Masson AM PLoS One; 2014; 9(3):e91000. PubMed ID: 24625450 [TBL] [Abstract][Full Text] [Related]
8. The clinical significance and prognostic value of Xenopus kinesin-like protein 2 expressions in human tumors: A systematic review and meta-analysis. Yang W; Wan H; Shan R; Wen W; Li J; Luo D; Wan RH J Cell Physiol; 2019 Sep; 234(9):14991-14998. PubMed ID: 30779127 [TBL] [Abstract][Full Text] [Related]
9. TPX2 as a prognostic indicator and potential therapeutic target in clear cell renal cell carcinoma. Glaser ZA; Love HD; Guo S; Gellert L; Chang SS; Herrell SD; Barocas DA; Penson DF; Cookson MS; Clark PE Urol Oncol; 2017 May; 35(5):286-293. PubMed ID: 28108243 [TBL] [Abstract][Full Text] [Related]
10. Overexpressed targeting protein for Xklp2 (TPX2) serves as a promising prognostic marker and therapeutic target for gastric cancer. Liang B; Zheng W; Fang L; Wu L; Zhou F; Yin X; Yu X; Zou Z Cancer Biol Ther; 2016 Aug; 17(8):824-32. PubMed ID: 27314162 [TBL] [Abstract][Full Text] [Related]
11. Astrocyte Elevated Gene-1 as a Novel Clinicopathological and Prognostic Biomarker for Gastrointestinal Cancers: A Meta-Analysis with 2999 Patients. Luo Y; Zhang X; Tan Z; Wu P; Xiang X; Dang Y; Chen G PLoS One; 2015; 10(12):e0145659. PubMed ID: 26710214 [TBL] [Abstract][Full Text] [Related]
12. MiR-29a-5p inhibits proliferation and invasion and induces apoptosis in endometrial carcinoma via targeting TPX2. Jiang T; Sui D; You D; Yao S; Zhang L; Wang Y; Zhao J; Zhang Y Cell Cycle; 2018; 17(10):1268-1278. PubMed ID: 29888640 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of TPX2 predicts poor clinical outcome and is associated with immune infiltration in hepatic cell cancer. Zhu H; Liu J; Feng J; Zhang Q; Bian T; Li X; Sun H; Zhang J; Liu Y Medicine (Baltimore); 2020 Dec; 99(49):e23554. PubMed ID: 33285774 [TBL] [Abstract][Full Text] [Related]
14. TPX2 is a novel prognostic marker for the growth and metastasis of colon cancer. Wei P; Zhang N; Xu Y; Li X; Shi D; Wang Y; Li D; Cai S J Transl Med; 2013 Dec; 11():313. PubMed ID: 24341487 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of LncRNA PVT1 Predicts Advanced Clinicopathological Features and Serves as an Unfavorable Risk Factor for Survival of Patients with Gastrointestinal Cancers. Liu F; Dong Q; Huang J Cell Physiol Biochem; 2017; 43(3):1077-1089. PubMed ID: 28968599 [TBL] [Abstract][Full Text] [Related]
16. TPX2 level correlates with cholangiocarcinoma cell proliferation, apoptosis, and EMT. Zou Z; Zheng B; Li J; Lv X; Zhang H; Yu F; Kong L; Li Y; Yu M; Fang L; Liang B Biomed Pharmacother; 2018 Nov; 107():1286-1293. PubMed ID: 30257343 [TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4. Yang C; Shen S; Zheng X; Ye K; Ge H; Sun Y; Lu Y FASEB J; 2020 May; 34(5):6055-6069. PubMed ID: 32239565 [TBL] [Abstract][Full Text] [Related]
18. Comprehensive Analysis of the Oncogenic Role of Targeting Protein for Xklp2 (TPX2) in Human Malignancies. Shao T; Jiang X; Bao G; Li C; Guo C Dis Markers; 2022; 2022():7571066. PubMed ID: 36304254 [TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of targeting protein for Xenopus kinesin-like protein 2 (TPX2) at threonine 72 in spindle assembly. Shim SY; Perez de Castro I; Neumayer G; Wang J; Park SK; Sanada K; Nguyen MD J Biol Chem; 2015 Apr; 290(14):9122-34. PubMed ID: 25688093 [TBL] [Abstract][Full Text] [Related]
20. Targeting TPX2 suppresses proliferation and promotes apoptosis via repression of the PI3k/AKT/P21 signaling pathway and activation of p53 pathway in breast cancer. Chen M; Zhang H; Zhang G; Zhong A; Ma Q; Kai J; Tong Y; Xie S; Wang Y; Zheng H; Guo L; Lu R Biochem Biophys Res Commun; 2018 Dec; 507(1-4):74-82. PubMed ID: 30454896 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]